home / stock / dtc / dtc news

DTC News and Press, Solo Brands Inc. Class A From 07/18/23

Stock Information
Company Name: Solo Brands Inc. Class A
Stock Symbol: DTC
Market: NYSE
Website: solostove.com
Menu
DTC DTC Quote DTC Short DTC News DTC Articles DTC Message Board
Get DTC Alerts

News, Short Squeeze, Breakout and More Instantly...
DTC - Defence Successfully Completes the First Milestone of Its Collaboration Agreement with Orano

Vancouver, British Columbia--(Newsfile Corp. - July 18, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company ") is pleased to announce that it has successfully reached the first milestone established in the Collaboration Agreement with Orano Supp...
DTC - RETRANSMISSION: Defence and Viewpoint with Dennis Quaid Join Forces to Explore Breakthroughs in Biotechnology

Vancouver, British Columbia--(Newsfile Corp. - July 5, 2023) - Defence Therapeutics Inc. (" Defence " or the " Company ") a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies is pleased to announce its collaboration with Viewpoint with Denn...

DTC - Defence and Viewpoint with Dennis Quaid Join Forces to Explore Breakthroughs in Biotechnology

Vancouver, British Columbia--(Newsfile Corp. - July 4, 2023) - Defence Therapeutics Inc. (" Defence " or the " Company ") a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies is pleased to announce its collaboration with Viewpoint with D...

DTC - Defence Patent Portfolio at the Forefront of Success

Vancouver, British Columbia--(Newsfile Corp. - June 28, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company ") is a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies. Sitting at the core ...
DTC - Defence's Proprietary Accum(TM) Technology for Delivery of CRISPR/Cas Genome-Editing Complexes Patent Application Published

Vancouver, British Columbia--(Newsfile Corp. - June 20, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce...

DTC - Defence Manufacturing of AccuTox(TM) CGMP Final Drug Product Optimization for Its Phase I Clinical Trial at City of Hope

Vancouver, British Columbia--(Newsfile Corp. - June 16, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies is ple...

DTC - Chubbies Launches George Kittle Limited Edition Collection

Chubbies Launches George Kittle Limited Edition Collection PR Newswire First drop co-designed by pro-football tight end and longtime fan of the brand, George Kittle . AUSTIN, Texas , June 7, 2023 /PRNewswire/ -- Chubbies, the weekend-centric lifestyle...
DTC - Defence Begins Testing Its Arm Vaccine Against Pancreatic Cancer

Vancouver, British Columbia--(Newsfile Corp. - June 6, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies is...

DTC - Solo Brands: Performance May Weaken

2023-05-31 00:29:22 ET Summary Solo Brands has seen a 13% YTD increase in stock value, with a non-GAAP TTM P/E ratio of 4.15x, lower than the consumer discretionary sector's 12.2x. The company's revenue growth is expected to slow down in 2023, but its adjusted EBITDA margin is for...

DTC - Defence Announces Additional and Final Exercises of Warrants for Gross Proceeds of Over $2.3 Million

Vancouver, British Columbia--(Newsfile Corp. - May 26, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is ple...
Previous 10 Next 10